At least 10% of the world population is affected by chronic kidney disease (CKD). This contributes significantly to burden of morbidity and mortality, making CKD an urgent public health priority. Whilst there are variations in quality of data, available evidence shows that risk, prevalence, and outcomes are unequal both within and between countries. Inequities are observed through the continuum from prevention and early diagnosis to management and outcomes. The ISN’s 10 recommendations for ‘good kidney health’ prioritise action to reduce such unfair and reasonably avoidable kidney health equity gaps.
Drawing on a recent review of evidence undertaken by Kidney Research UK, this session uses one system’s research roadmap for kidney health equity as a catalyst to discuss policy, practice, regulatory, and legislative drivers as instrumental in achieving fairer health for all. Through a series of short presentations and a panel discussion, the session will offer participants an opportunity to explore and develop an appreciation of:
Opportunities for global collaboration through platforms such as the ISN-GKHA, i3C, iNET-CKD, SharE-RR, and ISN-ACT as drivers of CKD integration in government health strategies, and clearer evidence on what interventions work and for whom.
Time | Session |
---|---|
11 a.m.
11:12 a.m.
|
SpS-Shiv-1
|
11:12 a.m.
11:24 a.m.
|
SpS-Shiv-2
|
11:24 a.m.
11:36 a.m.
|
SpS-Shiv-1
|